HIGHLIGHTS
- who: Yu-Hsuan Cheng et al. from the Department of Life Science, School of Life Science, College of Science, National Taiwan Normal University have published the research: Intrarenal Arterial Transplantation of Dexmedetomidine Preconditioning Adipose Stem-Cell-Derived Microvesicles Confers Further Therapeutic Potential to Attenuate Renal Ischemia/Reperfusion Injury through miR-122-5p/Erythropoietin/Apoptosis Axis, in the Journal: Antioxidants 2022, 11, 1702. https:// of 20/07/2022
- what: Through the enhancement of homing and tissue-regenerating ability.
- how: The authors evaluated the effect of DEX-MVs on NRK-52E cells migration hypoxia/reoxygenation . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.